Literature DB >> 11932133

Clinicians' views on treating posttraumatic stress disorder and substance use disorder.

Lisa M Najavits1.   

Abstract

The dual diagnosis of posttraumatic stress disorder (PTSD) and substance use disorder (SUD) is reported to be both highly prevalent and highly challenging. In this study, 147 clinicians were surveyed on their degree of difficulty and gratification in working with each disorder (PTSD, SUD) and their combination; specific types of difficulties and gratifications; and personal and professional characteristics. The dual diagnosis was perceived as more difficult than either disorder alone; but, interestingly, gratification in the work was higher than its difficulty. Areas of greatest difficulty were clients' self-destructiveness, case management, and dependency; areas of greatest gratification were teaching new coping, developing expertise, and helping clients achieve abstinence. In general, difficulty and gratification appeared to be separate constructs, rather than simply opposites. Those finding the work most difficult were more likely to be in a mental health setting and to have no personal history of trauma. Clinical implications are discussed. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11932133     DOI: 10.1016/s0740-5472(02)00219-2

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  14 in total

Review 1.  Future directions for interventions targeting PTSD in HIV-infected adults.

Authors:  Allison J Applebaum; C Andres Bedoya; Ellen S Hendriksen; Jesse L Wilkinson; Steven A Safren; Conall O'Cleirigh
Journal:  J Assoc Nurses AIDS Care       Date:  2014-11-10       Impact factor: 1.354

2.  Reductions in traumatic stress following a coping intervention were mediated by decreases in avoidant coping for people living with HIV/AIDS and childhood sexual abuse.

Authors:  Kathleen J Sikkema; Krista W Ranby; Christina S Meade; Nathan B Hansen; Patrick A Wilson; Arlene Kochman
Journal:  J Consult Clin Psychol       Date:  2012-10-01

3.  Clinician Perspectives on Treating Adolescents with Co-occurring Post-Traumatic Stress Disorder, Substance Use, and Other Problems.

Authors:  Zachary W Adams; Jenna L McCauley; Sudie E Back; Julianne C Flanagan; Rochelle F Hanson; Therese K Killeen; Carla Kmett Danielson
Journal:  J Child Adolesc Subst Abuse       Date:  2016-06-10

4.  A pilot study of seeking safety therapy with OEF/OIF veterans.

Authors:  Sonya B Norman; Kendall C Wilkins; Susan F Tapert; Ariel J Lang; Lisa M Najavits
Journal:  J Psychoactive Drugs       Date:  2010-03

5.  A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders.

Authors:  Mark P McGovern; Chantal Lambert-Harris; Stephanie Acquilano; Haiyi Xie; Arthur I Alterman; Roger D Weiss
Journal:  Addict Behav       Date:  2009-03-14       Impact factor: 3.913

6.  Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives.

Authors:  Sudie E Back; Angela E Waldrop; Kathleen T Brady
Journal:  Am J Addict       Date:  2009 Jan-Feb

7.  An Exploratory Investigation of the Association between Clinicians' Attitudes toward Twelve-step Groups and Referral Rates.

Authors:  Alexandre B Laudet; William L White
Journal:  Alcohol Treat Q       Date:  2005-04-06

Review 8.  Harm reduction therapy: a practice-friendly review of research.

Authors:  Diane E Logan; G Alan Marlatt
Journal:  J Clin Psychol       Date:  2010-02

9.  Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial.

Authors:  Eric L Garland; Amelia Roberts-Lewis; Christine D Tronnier; Rebecca Graves; Karen Kelley
Journal:  Behav Res Ther       Date:  2015-11-27

10.  What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment.

Authors:  Alexandre B Laudet; Virginia Stanick; Brian Sands
Journal:  J Subst Abuse Treat       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.